554 related articles for article (PubMed ID: 24914577)
1. Characterization of exhaled particles from the human lungs in airway obstruction.
Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
[TBL] [Abstract][Full Text] [Related]
2. Characterization of exhaled particles from the healthy human lung--a systematic analysis in relation to pulmonary function variables.
Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):371-9. PubMed ID: 20500095
[TBL] [Abstract][Full Text] [Related]
3. Exhaled particles as markers of small airway inflammation in subjects with asthma.
Larsson P; Lärstad M; Bake B; Hammar O; Bredberg A; Almstrand AC; Mirgorodskaya E; Olin AC
Clin Physiol Funct Imaging; 2017 Sep; 37(5):489-497. PubMed ID: 26648443
[TBL] [Abstract][Full Text] [Related]
4. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E
Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939
[TBL] [Abstract][Full Text] [Related]
5. Exhaled biomarkers.
Kharitonov SA; Barnes PJ
Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
[TBL] [Abstract][Full Text] [Related]
6. Effects of cigarette smoke on methacholine- and AMP-induced air trapping in asthmatics.
Prieto L; Palop J; Llusar R; Herrera S; Perez-Frances C; Lanuza A; Aguilar D
J Asthma; 2015 Feb; 52(1):26-33. PubMed ID: 25019351
[TBL] [Abstract][Full Text] [Related]
7. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath condensate biomarkers in COPD.
Borrill ZL; Roy K; Singh D
Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
[TBL] [Abstract][Full Text] [Related]
9. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
11. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
12. Exhaled breath condensate formate after inhaled allergen provocation in atopic asthmatics in vivo.
Greenwald R; Johnson BA; Hoskins A; Dworski R
J Asthma; 2013 Aug; 50(6):619-22. PubMed ID: 23557458
[TBL] [Abstract][Full Text] [Related]
13. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.
Corradi M; Montuschi P; Donnelly LE; Pesci A; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 2001 Mar; 163(4):854-8. PubMed ID: 11282756
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease.
Borrill Z; Starkey C; Vestbo J; Singh D
Eur Respir J; 2005 Feb; 25(2):269-74. PubMed ID: 15684290
[TBL] [Abstract][Full Text] [Related]
15. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
Donohue JF; Herje N; Crater G; Rickard K
Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
[TBL] [Abstract][Full Text] [Related]
16. Ambient temperature impacts on pH of exhaled breath condensate.
Koczulla AR; Noeske S; Herr C; Dette F; Pinkenburg O; Schmid S; Jörres RA; Vogelmeier C; Bals R
Respirology; 2010 Jan; 15(1):155-9. PubMed ID: 19947991
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.
Papaioannou AI; Loukides S; Minas M; Kontogianni K; Bakakos P; Gourgoulianis KI; Alchanatis M; Papiris S; Kostikas K
Respir Res; 2011 May; 12(1):67. PubMed ID: 21600044
[TBL] [Abstract][Full Text] [Related]
18. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Methacholine Challenge Testing and exhaled nitric oxide in adult patients with suspected bronchial asthma.
Giovannini M; Valli M; Ribuffo V; Melara R; Cappiello G; Businarolo E; Andreani A
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):109-13. PubMed ID: 24853569
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD.
Murata K; Fujimoto K; Kitaguchi Y; Horiuchi T; Kubo K; Honda T
COPD; 2014 Feb; 11(1):81-7. PubMed ID: 24111595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
